SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-284985
Filing Date
2013-07-08
Accepted
2013-07-08 17:26:52
Documents
8
Group Members
AVALON VENTURES IX, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d565172dsc13d.htm SC 13D 62092
2 EX-99.A d565172dex99a.htm EX-99.A 4220
3 EX-99.B d565172dex99b.htm EX-99.B 96005
4 EX-99.C d565172dex99c.htm EX-99.C 126248
5 EX-99.D d565172dex99d.htm EX-99.D 134234
6 EX-99.G d565172dex99g.htm EX-99.G 17413
7 EX-99.H d565172dex99h.htm EX-99.H 11060
8 EX-99.I d565172dex99i.htm EX-99.I 8187
  Complete submission text file 0001193125-13-284985.txt   460924
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Subject) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87524 | Film No.: 13958165
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1134 KLINE ST LA JOLLA CA 92037
Business Address 1134 KLINE ST LA JOLLA CA 92037 858-348-2179
Avalon Ventures IX GP, LLC (Filed by) CIK: 0001578781 (see all company filings)

IRS No.: 272359411 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D